Journal Scans
Risk of Second Cancers in Waldenstrom Macroglobulinemia
Risk for Second Cancer Increased in Waldenström Macroglobulinemia
M Varettoni, A Tedeschi, L Arcaini, C Pascutto, E Vismara, E Orlandi, F Ricci, A Corso, A Greco, S Mangiacavalli, M Lazzarino, E Morra
20110327
2011 Apr 27
Ann Oncol
Risk of Second Cancers in Waldenstrom Macroglobulinemia
Ann Oncol. 2011 Apr 27;[Epub Ahead of Print], M Varettoni, A Tedeschi, L Arcaini, C Pascutto, E Vismara, E Orlandi, F Ricci, A Corso, A Greco, S Mangiacavalli, M Lazzarino, E Morra
TAKE-HOME MESSAGE
Abstract
SUMMARY
OncologySTAT Editorial Team
There are several reports of increased incidence of second cancers in patients with more common lymphoproliferative diseases, such as non-Hodgkin’s lymphoma and chronic lymphocytic leukemia. In contrast, little is known about the occurrence of second cancers in patients with Waldenström macroglobulinemia (WM), with information limited to reports of increased risk of myelodysplastic syndrome (MDS)/acute myeloid leukemia (AML) in patients treated with nucleoside analogues. In this retrospective analysis,...
